TickerFacts.

Aytu Biopharma, Inc (AYTU): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2015-06-30, 2022-06-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Total Liabilities is for the year ended 2023-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$97.11M
As of 2023-06-30
$128.10M2014-06-30: $6.65M2015-06-30: $2.57M2016-06-30: $14.26M2017-06-30: $11.00M2018-06-30: $7.64M2019-06-30: $27.63M2020-06-30: $58.28M2021-06-30: $128.10M2022-06-30: $93.31M2023-06-30: $97.11M$97.11M
2014-06-30 Total Liabilities (USD) 2023-06-30
Period endedTotal LiabilitiesChange YoYSource filing
2023-06-30$97.11M+4.1%2023-10-12, Balance as of period end
2022-06-30$93.31Mn/c2023-10-12, Balance as of period end
2021-06-30$128.10M+119.8%2022-09-27, Balance as of period end
2020-06-30$58.28M+110.9%2021-09-28, Balance as of period end
2019-06-30$27.63M+261.9%2020-10-06, Balance as of period end
2018-06-30$7.64M-30.6%2019-09-26, Balance as of period end
2017-06-30$11.00M-22.9%2018-09-06, Balance as of period end
2016-06-30$14.26M+455.0%2017-08-31, Balance as of period end
2015-06-30$2.57Mn/c2016-09-01, Balance as of period end
2014-06-30$6.65Mn/a2015-09-28, Balance as of period end